From: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies
Estimated dose to the public [μSv] after 1 cycle of 177Lu-PSMA-617 therapy | |||||||||
---|---|---|---|---|---|---|---|---|---|
Time point of discharge | 24 h p. i.a | 48 h p. i. | 72 h p. i.b | ||||||
Type of half-life | T 1/2ind | T 1/2phys | T 1/2max | T 1/2ind | T 1/2phys | T 1/2max | T 1/2ind | T 1/2phys | T 1/2max |
Mean | 99 | 396 | 208 | 71 | 263 | 139 | 50 | 200 | 105 |
Std. Dev. | 58 | 131 | 69 | 51 | 100 | 53 | 35 | 76 | 40 |
Min | 25 | 142 | 75 | 13 | 93 | 49 | 17 | 93 | 49 |
Max | 318 | 779 | 410 | 264 | 560 | 294 | 204 | 443 | 233 |